Add like
Add dislike
Add to saved papers

Barriers that impede the safety of medicinal products for children.

The European Paediatric Regulation 2007 was introduced to improve development of high quality medicines for children. A lack of appropriate medicines for this client group is an extensive and well-documented problem and the use of off-label and unlicensed medication is a widespread practice. Ernest et al ( 2007 ) state that most drugs are not labelled, or are inadequately labelled, for use in child patients. Critical safety and efficacy information is lacking and poses significant risks to this vulnerable population.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app